Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.

Psychopharmacology bulletin

Volumn 37, Issue 3, 2003, Pages 90-98

  Corey Lisle, Patricia K ^a   Birnbaum, Howard ^a   Greenberg, Paul ^a   Marynchenko, Maryna ^a   Dube, Sanjay ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUOXETINE; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; PILOT STUDY; PSYCHOLOGICAL ASPECT; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; BENZODIAZEPINES; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PILOT PROJECTS; SEROTONIN UPTAKE INHIBITORS; UNITED STATES;

EID: 4644270438     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)